Sino Medical Sciences Technology 688108.SS · CNY

Its shares trade on Shanghai under the ticker 688108.SS. It has been listed since 30 October 2019. In the fiscal year to 31 December 2025, it reported revenue of CN¥525.4m and net income of CN¥47.3m. At that date it held total assets of CN¥1.35bn and shareholders' equity of CN¥931.8m.

Sino Medical Sciences Technology, Inc. engages in the research, development, production, and sale of interventional medical devices. The company is headquartered in Tianjin, Tianjin. The company went IPO on 2019-10-30. The firm's product pipeline covers the field of interventional therapy such as cardiovascular, cerebrovascular, and structural heart disease. The firm's main products include coronary drug stent system and balloon dilatation catheters. The firm conducts its businesses within the domestic market and overseas markets, and it has subsidiaries in Beijing, China, Hong Kong, China, the United States, Japan, the Netherlands, and France.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Jianhua SunChairman of the Board, General Manager, since 2018CN¥1.3m
• Ms. Lihua ShenChief Financial Officer, Director, since 2013CN¥1.2m
• Mr. Xiaoran KangDeputy General Manager, Director, since 2018CN¥1.3m
• Mr. Liye CuiDeputy General Manager - Production and Operations, since 2018CN¥945,400
• Mr. Kai HuangSecretary of the Board, Director, since 2018CN¥487,500
• Mr. Wenbin CaiDirectorCN¥1.0m
• Ms. Lin ChenDirectorCN¥918,400
• Mr. Ya GaoIndependent DirectorCN¥80,000
• Ms. Rui LiIndependent DirectorCN¥80,000
• Mr. Changchun YuIndependent DirectorCN¥80,000

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.